Fig. 7. Arctigenin reduced the phosphorylation of proteins in the MAPKs, NF-κB, and AKT pathways in FaDu pharyngeal cells.
FaDu cells were treated with 0, 50, and 100 μM Arctigenin for 24 h. Thereafter, immunoblotting using specific antibodies against extracellular signal-regulated kinase 1/2 (ERK1/2), p38, NFκB, and AKT was performed to verify potential cellular signaling pathways associated with Arctigenin-induced apoptosis.
© Korean J Physiol Pharmacol
